Natural history and treatment of chronic delta hepatitis
Tóm tắt
Từ khóa
Tài liệu tham khảo
Rizzetto, 1977, Immunofluorescence detection of new antigen-antibody system (delta/anti-delta) associated to hepatitis B virus in liver and in serum of HBsAg carriers, Gut, 18, 997, 10.1136/gut.18.12.997
Taylor, 1996, Fundamental Virology, 1235
Salehi-Ashtiani, 2006, A genomewide search for ribozymes reveals an HDV-like sequence in the human CPEB3 gene, Science, 313, 1788, 10.1126/science.1129308
Sagnelli, 1997, Decrease in HDV endemicity in Italy, J Hepatol, 26, 20, 10.1016/S0168-8278(97)80004-9
Gaeta, 2000, Chronic hepatitis D: a vanishing Disease? An Italian multicenter study, Hepatology, 32, 824, 10.1053/jhep.2000.17711
Huo, 1997, Decreasing hepatitis D virus infection in Taiwan: an analysis of contributory factors, J Gastroenterol Hepatol, 12, 747, 10.1111/j.1440-1746.1997.tb00364.x
Değertekin, 2008, Seropositivity for delta hepatitis in patients with chronic hepatitis B and liver cirrhosis in Turkey: a meta-analysis, Liver Int, 28, 494, 10.1111/j.1478-3231.2008.01673.x
Wedemeyer, 2007, Hepatitis D virus infection- not a vanishing disease in Europe!, Hepatology, 45, 1331, 10.1002/hep.21590
Gaeta, 2007, Hepatitis delta in Europe: vanishing or refreshing?, Hepatology, 46, 1312, 10.1002/hep.21816
Le Gal, 2007, Hepatitis D virus infection: not a vanishing disease in Europe!, Hepatology, 45, 1332, 10.1002/hep.21652
Cross, 2008, The increasing prevalence of hepatitis delta virus infection in Southern London, J Med Virol, 80, 277, 10.1002/jmv.21078
Rizzetto, 1980, Transmission of hepatitis B virus-associated delta antigen in chimpanzees, J Infect Dis, 141, 590, 10.1093/infdis/141.5.590
Caredda, 1985, Hepatitis B virus-associated coinfection and superinfection with ∂ agent: indistinguishable disease with different outcome, J Infect Dis, 151, 925, 10.1093/infdis/151.5.925
Smedile, 1982, Influence of delta infection on severity of hepatitis B, Lancet, ii, 945, 10.1016/S0140-6736(82)90156-8
Govindarajan, 1984, Fulminant B viral hepatitis: role of delta agent, Gastroenterology, 86, 1417, 10.1016/S0016-5085(84)80153-5
Caredda, 1987, Course and prognosis of acute HDV patients, Prog Clin Biol Res, 364, 267
Smedile, 1994, Advances in hepatitis D virus biology and disease, Prog Liver Dis, 12, 157
Rizzetto, 1983, Chronic hepatitis in carriers of hepatitis B surface antigen, with intrahepatic expression of the delta antigen, Ann Intern Med, 98, 437, 10.7326/0003-4819-98-4-437
Negro, 1988, Chronic HDV hepatitis. Intrahepatic expression of delta antigen, histologic activity and outcome of liver disease, J Hepatol, 6, 8, 10.1016/S0168-8278(88)80457-4
Nisini, 1997, Human CD4+ T-cell response to hepatitis delta virus: identification of multiple epitopes and characterization of T-helper cytokine profiles, J Virol, 71, 2241, 10.1128/JVI.71.3.2241-2251.1997
Aslan, 2006, Cytotoxic CD4+ T cells in viral hepatitis, J Viral Hepat, 13, 505, 10.1111/j.1365-2893.2006.00723.x
Sarin, 2009, Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific Association for the study of the liver, Hepatol Int, 3, 269, 10.1007/s12072-008-9106-x
Liaw, 2004, Impact of acute hepatitis C virus superinfection in patients with chronic hepatitis B virus infection, Gastroenterology, 126, 1024, 10.1053/j.gastro.2004.01.011
Bonino, 1987, The natural history of chronic delta hepatitis, Prog Clin Biol Res, 234, 145
Ponzetto, 1988, Serial passage of hepatitis delta virus in chronic hepatitis B virus carrier chimpanzees, Hepatology, 8, 1655, 10.1002/hep.1840080631
Smedile, 1991, Hepatitis B virus replication modulates pathogenesis of hepatitis D virus in chronic hepatitis D, Hepatology, 13, 413, 10.1002/hep.1840130305
Su, 2006, Genotypes and viremia of hepatitis B and D viruses are associated with outcomes of chronic hepatitis D patients, Gastroenterology, 130, 1625, 10.1053/j.gastro.2006.01.035
Lin, 1989, Natural course of patients with chronic type B hepatitis following acute hepatitis delta virus superinfection, Liver, 9, 129, 10.1111/j.1600-0676.1989.tb00389.x
Radjef, 2004, Molecular phylogenetic analyses indicate a wide and ancient radiation of African hepatitis delta virus, suggesting a deltavirus genus of at least seven major clades, J Virol, 78, 2537, 10.1128/JVI.78.5.2537-2544.2004
Makuwa, 2008, Prevalence and genetic diversity of hepatitis B and delta viruses in pregnant women in Gabon: molecular evidence that hepatitis delta virus clade 8 originates from and is endemic in Cental Africa, J Clin Microbiol, 46, 754, 10.1128/JCM.02142-07
Shakil, 1997, Geographic distribution and genetic variability of hepatitis delta virus genotype I, Virology, 234, 160, 10.1006/viro.1997.8644
Casey, 1996, Hepatitis B virus (HBV)/hepatitis D virus (HDV) coinfection in outbreaks of acute hepatitis in the Peruvian Amazon Basin: the roles of genotype III and HBV genotype F, J Infect Dis, 174, 920, 10.1093/infdis/174.5.920
Wu, 1995, Genotyping of hepatitis D with restriction-fragment length polymorphism and relation to outcome of hepatitis D, Lancet, 346, 939, 10.1016/S0140-6736(95)91558-3
Lee, 1996, Characterization of a new genotype II hepatitis delta virus from Taiwan, J Med Virol, 49, 145, 10.1002/(SICI)1096-9071(199606)49:2<145::AID-JMV12>3.0.CO;2-D
Watanabe, 2003, Chronic hepatitis delta virus infection with genotype IIb variant is correlated with progressive liver disease, J Gen Virol, 84, 3275, 10.1099/vir.0.19499-0
Kiesslich, 2009, Influence of hepatitis B virus (HBV) genotype on the clinical course of disease in patients coinfected with HBV and hepatitis delta virus, J Infect Dis, 199, 1608, 10.1086/598955
Hsu, 2002, Varied assembly and RNA editing efficiencies between genotypes I and II hepatitis D virus and their implications, Hepatology, 35, 665, 10.1053/jhep.2002.31777
Lin, 2003, Initiation of RNA replication of cloned Taiwan-3 isolate of hepatitis delta virus genotype II in cultured cells, Biochem Biophys Res Commun, 306, 966, 10.1016/S0006-291X(03)01076-3
Rosina, 1999, Changing pattern of chronic hepatitis D in southern Europe, Gastroenterology, 117, 161, 10.1016/S0016-5085(99)70563-9
Romeo, 2009, A 28-year study of the course of hepatitis D infection: a risk factor for cirrhosis and hepatocellular carcinoma, Gastroenterology, 136, 1629, 10.1053/j.gastro.2009.01.052
Fattovich, 2000, Influence of hepatitis delta virus infection on morbidity and mortality in compensated cirrhosis type B, Gut, 46, 420, 10.1136/gut.46.3.420
Farci, 1994, Treatment of chronic hepatitis D with interferon alfa-2a, N Engl J Med, 330, 88, 10.1056/NEJM199401133300202
Madejon, 1994, Treatment of chronic hepatitis D virus infection with low and high doses of interferon-alpha 2a: utility of polymerase chain reaction in monitoring antiviral response, Hepatology, 19, 1331, 10.1002/hep.1840190602
Gaudin, 1995, The French experience of treatment of chronic type D hepatitis with a 12-month course of interferon alpha-2B. Results of a randomized controlled trial, Liver, 15, 45, 10.1111/j.1600-0676.1995.tb00106.x
Farci, 2004, Long-term benefit of interferon alpha therapy of chronic hepatitis D: regression of advanced hepatic fibrosis, Gastroenterology, 126, 1740, 10.1053/j.gastro.2004.03.017
Lampertico, 2003, Long-term supression of hepatitis B e antigen-negative chronic hepatitis B by 24-month interferon therapy, Hepatology, 37, 756, 10.1053/jhep.2003.50148
Lau, 1999, Resolution of chronic delta hepatitis after 12 years of interferon alfa therapy, Gastroenterology, 117, 1229, 10.1016/S0016-5085(99)70409-9
Di Marco, 1996, Long-term interferon-alfa treatment of children with chronic hepatitis delta: a multicentre study, J Viral Hepat, 3, 123, 10.1111/j.1365-2893.1996.tb00002.x
Yurdaydın, 2007, A pilot study of two years of interferon in patients with chronic delta hepatitis, J Viral Hepat, 14, 812, 10.1111/j.1365-2893.2007.00875.x
Günsar, 2005, Two-year interferon therapy with or without ribavirin in chronic delta hepatitis, Antivir Ther, 10, 721, 10.1177/135965350501000603
Niro, 2006, Pegylated interferon alpha-2b as monotherapy or in combination with ribavirin in chronic hepatitis delta, Hepatology, 44, 713, 10.1002/hep.21296
Erhardt, 2006, Treatment of chronic hepatitis delta with pegylated interferon-alpha2b, Liver Int, 26, 805, 10.1111/j.1478-3231.2006.01279.x
Castelnau, 2006, Efficacy of peginterferon alpha-2b in chronic hepatitis delta: relevance of quantitative RT-PCR for follow-up, Hepatology, 44, 728, 10.1002/hep.21325
Wedemeyer, 2007, 72 week data of the HIDIT-1 trial: multicenter randomized study comparing peginterferon α-2a plus adefovir vs. peginterferon α-2a plus placebo vs. adefovir in chronic delta hepatitis (abstr.), J Hepatol, 46, S4, 10.1016/S0168-8278(07)61602-X
Yurdaydin, 2008, Treatment of chronic delta hepatitis with lamivudine vs. lamivudine + interferon vs. interferon, J Viral Hepat, 15, 314, 10.1111/j.1365-2893.2007.00936.x
Marzano, 1992, Treatment of early chronic delta hepatitis with lymphoblastoid alpha interferon: a pilot study, Ital J Gastroenterol, 24, 119
Rasshofer, 1991, Interference of antiviral substances with replication of hepatitis delta virus RNA in primary woodchuck hepatocytes, Prog Clin Biol Res, 364, 223
Garripoli, 1994, Ribavirin treatment for chronic hepatitis D: a pilot study, Liver, 14, 154, 10.1111/j.1600-0676.1994.tb00065.x
Niro, 2005, Lamivudine therapy in chronic delta hepatitis: a multicentre randomized-controlled pilot study, Aliment Pharmacol Ther, 22, 227, 10.1111/j.1365-2036.2005.02542.x
Yurdaydın, 2002, Famciclovir treatment of chronic delta hepatitis, J Hepatol, 37, 266, 10.1016/S0168-8278(02)00162-9
Önder, 2009, Entecavir may be beneficial in a subset of patients with chronic delta hepatitis (abstr.), Hepatology, 50, 735A
Yurdaydın, 2008, Treatment of HBeAg-positive chronic delta hepatitis with nucleos(t)ide analogs (abstr.), Hepatology, 48, 722A
Heidrich, 2008, HBeAg-positive chronic delta hepatitis: virological, biochemical and clinical features in a large European data base (abstr.), Hepatology, 48, 1184A
Peek, 2001, Antiviral activity of clevudine[L-FMAU,(1-(2-fluoro-5-methyl-β,L-arabinofuranosyluracil)] against woodchuck hepatitis virus replication and gene expression in chronically infected woodchucks (Marmota monax), Hepatology, 33, 254, 10.1053/jhep.2001.20899
Casey, 2005, Clevudine inhibits hepatitis delta virus viremia: a pilot study of chronically infected woodchucks, Antimicrob Agents Chemother, 49, 4396, 10.1128/AAC.49.10.4396-4399.2005
Kim, 2009, Clevudine myopathy in patients with chronic hepatitis B, J Hepatol, 51, 787, 10.1016/j.jhep.2009.04.019
Wolters, 2000, Lamivudine-high dose interferon combination therapy for chronic hepatitis B patients co-infected with the hepatitis D virus, J Viral Hepat, 7, 428, 10.1046/j.1365-2893.2000.00254.x
Canbakan, 2006, Efficacy of interferon alpha-2b and lamivudine combination treatment in comparison to interferon alpha-2b alone in chronic delta hepatitis: a randomized trial, J Gastroenterol Hepatol, 21, 657, 10.1111/j.1440-1746.2006.04082.x
Kaymakoğlu, 2005, Alpha interferon and ribavirin combination therapy of chronic hepatitis D, Antimicrob Agents Chemother, 49, 1135, 10.1128/AAC.49.3.1135-1138.2005
Zachou, 2010, Quantitative HBsAg and HDV RNA levels in chronic delta hepatitis, Liver Int, 30, 430, 10.1111/j.1478-3231.2009.02140.x
Manesis, 2007, Quantitative analysis of hepatitis D virus RNA and hepatitis B surface antigen serum levels in chronic delta hepatitis improves treatment monitoring, Antivir Ther, 12, 381, 10.1177/135965350701200307
Brunetto, 2009, Hepatitis B virus surface antigen levels: a guide to sustained response to peginterferon alpha-2a in HBeAg-negative chronic hepatitis B, Hepatology, 49, 1141, 10.1002/hep.22760
Rosina, 2002, Treatment of chronic hepatitis D with thymus-derived polypeptide thymic humoral factor-gamma 2: a pilot study, Dig Liver Dis, 34, 285, 10.1016/S1590-8658(02)80149-9
Arrigoni, 1983, Levamisole and chronic delta hepatitis, Ann Intern Med, 98, 1024, 10.7326/0003-4819-98-6-1024_1
Glenn, 1999, Shutting the door on hepatitis delta virus: sensitivity to prenylation inhibition prompts new therapeutic strategy, Viral Hepat Rev, 5, 13
Engelke, 2006, Characterization of a hepatitis B and hepatitis delta virus receptor binding site, Hepatology, 43, 750, 10.1002/hep.21112
Schulze, 2007, Hepatitis B virus infection initiates with a large surface protein-dependent binding to heparin sulfate proteoglycans, Hepatology, 46, 1759, 10.1002/hep.21896
Petersen, 2008, Prevention of hepatitis B virus infection in vivo by entry inhibitors derived from the large envelope protein, Nat Biotechnol, 26, 335, 10.1038/nbt1389
Mehta, 1998, α-Glucosidase inhibitors as potential broad based anti-viral agents, FEBS Lett, 430, 17, 10.1016/S0014-5793(98)00525-0
Wang, 2006, Hepatitis B virus pre-S mutants, endoplasmic reticulum stres and hepatocarcinogenesis, Cancer Sci, 97, 683, 10.1111/j.1349-7006.2006.00235.x
Liu, 2007, The degradation pathway for the HBV envelope proteins involves proteolysis prior to degradation via the cytosolic proteasome, Virology, 369, 69, 10.1016/j.virol.2007.06.048
Glenn, 1992, Identification of a prenylation site in delta virus large antigen, Science, 256, 1331, 10.1126/science.1598578
Glenn, 1998, Use of a prenylation inhibitor as a novel antiviral agent, J Virol, 72, 9303, 10.1128/JVI.72.11.9303-9306.1998
Bordier, 2002, A prenylation inhibitor prevents production of infectious hepatitis delta virus particles, J Virol, 76, 10465, 10.1128/JVI.76.20.10465-10472.2002
Bordier, 2003, In vivo antiviral efficacy of prenylation inhibitors against hepatitis delta virus, J Clin Invest, 112, 407, 10.1172/JCI17704